Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 10/20 | 0.45 |
| ▸ | F10 | P00742 | 4/20 | 0.36 |
| ▸ | MALT1 | Q9UDY8 | 5/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27718617 | 0.91 | P2RY12 (0.46) | P2RY12F10MALT1CYP2C9CYP1A2 | |
| SCHEMBL27698119 | 0.90 | P2RY12 (0.45) | P2RY12F10MALT1CYP2C9CYP1A2 | |
| SCHEMBL27698084 | 0.87 | P2RY12 (0.48) | P2RY12F10MALT1CYP2C9CYP1A2 | |
| SCHEMBL27718616 | 0.87 | P2RY12 (0.43) | P2RY12F10MALT1CYP2C9CYP1A2 | |
| SCHEMBL4099897 | 0.86 | P2RY12 (0.59) | P2RY12MALT1CYP2C9CYP1A2CYP3A4 | |
| SCHEMBL28772018 | 0.84 | P2RY12 (0.45) | P2RY12F10CYP2C9CYP1A2CYP3A4 | |
| SCHEMBL28769429 | 0.84 | P2RY12 (0.45) | P2RY12F10MALT1CYP2C9CYP1A2 | |
| SCHEMBL27718611 | 0.84 | P2RY12 (0.43) | P2RY12F10MALT1CYP2C9CYP1A2 | |
| SCHEMBL27698048 | 0.84 | P2RY12 (0.44) | P2RY12F10CYP2C9CYP1A2CYP3A4 | |
| SCHEMBL27698024 | 0.83 | P2RY12 (0.43) | P2RY12F10CYP2C9CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101137643-A | Novel pyridine compounds | ASTRAZENECA AB (SE) | 2008-03-05 | — | — | CN | disclosed |